R&D Experimental Services: COVID-19 Vaccine Development

Vaccine development is a long process that involves many steps in vitro and in vivo (preclinical, in laboratories) and in human volunteers and patients (clinical, in hospitals).

Started a project with a lead vaccine, or with a technology that could be used to develop a candidate vaccine can require many competencies. As access to such ressources can be limiting, many projects are on hold or cancelled. As the pandemic of COVID-19 is not over, and more outbreaks like SARS-CoV-2 could happen in the future, it is urgent to facilitate access to external ressources.

 This is why Labtoo developed a tailor-made service to support Labs, Biotechs, Medtech, and Pharma companies in their SARS-CoV-2 vaccine research programs.

Labtoo offers many types of SARS-CoV-2 experimental services,  for the development of new vaccine therapeutics. We work with a large international network of laboratories and service companies to provide the largest options for your project.

Select your COVID-19 vaccine treatment preclinical Service

 

We are specialized in tailor-made preclinical projects for the pharmaceutical and biotech industry.

Select your option and start building your project.

Labtoo services icon

What is included in our services?

Our team will handle your R&D service management from the beginning to the end

Perform a feasibility study by looking for existing expertise available within the network of partners


Set up a study protocol, financial quotation and preparing contracts with lab partners


Implement the study plan into a schedule, collect all needed materials and reagents and execute the service

Do you need more information about our experimental services?

favicon large un peu plus-1